Table 2.
Characteristics of 1,089 study subjects in 266 VAGES families
| Characteristics | |
|---|---|
| Subjects, na | 1,089 |
| Age, years | 49.9 ± 13.3 |
| Gender (% females) | 65 |
| Type 2 diabetes | 69 |
| Anti-hypertensive medicationb | 37 |
| Systolic blood pressure, mm Hg | 130.9 ± 19.4 |
| Model 1 systolic blood pressure, mm Hg | 136.2 ± 23.3 |
| Model 2 systolic blood pressure, mm Hg | 133.6 ± 19.1 |
| Diastolic blood pressure, mm Hg | 74.9 ± 11.0 |
| Model 1 diastolic blood pressure, mm Hg | 78.6 ± 12.6 |
| Model 2 diastolic blood pressure, mm Hg | 80.0 ± 11.8 |
| Body mass index | 33.2 ± 7.9 |
| ln body mass index | 3.5 ± 0.2 |
Figures are means ± SD or %, unless otherwise indicated.
ln = log transformed.
a
The analyses included 37 unrelated individuals in addition to the 1,089 subjects from the VAGES.
b
Antihypertensive treatment included all current medications including angiotensin-converting enzyme (ACE) or angiotensin receptor blocker (ARB).